Literature DB >> 2733733

Reduction of nosocomial infection during pediatric intensive care by protective isolation.

B S Klein1, W H Perloff, D G Maki.   

Abstract

To determine whether simple protective isolation reduces the incidence of nosocomial bacterial and fungal infection during pediatric intensive care, we randomly assigned 70 children who were not immuno-suppressed and who required mechanical ventilatory support and three or more days of intensive care to receive standard care (n = 38) or protective isolation (n = 32) with use of disposable, non-waven, polypropylene gowns and nonsterile latex gloves. Risk factors predisposing patients to infection were comparable in the two groups. Nosocomial colonization occurred later among isolated patients (median, vs. 7 days; P less than 0.01) and was associated with subsequent infection in 12 patients, as compared with 12 patients given standard care (P = 0.01). Among patients who were isolated, the interval before the first infection was significantly longer than (median, 20 vs. 8 days; P = 0.04), the daily infection rate was 2.2 times lower than (95 percent confidence interval, 1.2 to 4.0; P = 0.007), and there were fewer days with fewer (13 percent vs. 21 percent; P = 0.001). The benefit of isolation was most notable after seven days of intensive care. Isolation was well tolerated by patients and their families. Regular monitoring showed that the children in each group were touched and handled comparably often by hospital personnel and family members. We conclude that the use of disposable, high-barrier gowns and gloves for the care of selected, high-risk children who require prolonged intensive care significantly reduces the incidence of nosocomial infection, is well tolerated, and does not compromise the delivery of care.

Entities:  

Mesh:

Year:  1989        PMID: 2733733     DOI: 10.1056/NEJM198906293202603

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  23 in total

1.  Nosocomial or Healthcare Facility-Related Pneumonia in Adults.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

2.  Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria.

Authors:  E Raineri; L Crema; S Dal Zoppo; A Acquarolo; A Pan; G Carnevale; F Albertario; A Candiani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

3.  Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events.

Authors:  J R Zahar; M Garrouste-Orgeas; A Vesin; C Schwebel; A Bonadona; F Philippart; C Ara-Somohano; B Misset; J F Timsit
Journal:  Intensive Care Med       Date:  2013-08-31       Impact factor: 17.440

Review 4.  Nosocomial pneumonia: epidemiology and infection control.

Authors:  D E Craven; K A Steger; L M Barat; R A Duncan
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 5.  Control of antibiotic-resistant bacteria in the office and clinic.

Authors:  Anne G Matlow; Shaun K Morris
Journal:  CMAJ       Date:  2009-05-12       Impact factor: 8.262

6.  Infection prevention by selective decontamination in intensive care.

Authors:  W G Johanson
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 7.  Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting.

Authors:  Jesús López-Alcalde; Marta Mateos-Mazón; Marcela Guevara; Lucieni O Conterno; Ivan Solà; Sheila Cabir Nunes; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2015-07-16

Review 8.  Drug utilisation in preterm and term neonates.

Authors:  L Gortner
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

9.  Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial.

Authors:  Anthony D Harris; Lisa Pineles; Beverly Belton; J Kristie Johnson; Michelle Shardell; Mark Loeb; Robin Newhouse; Louise Dembry; Barbara Braun; Eli N Perencevich; Kendall K Hall; Daniel J Morgan; Syed K Shahryar; Connie S Price; Joseph J Gadbaw; Marci Drees; Daniel H Kett; L Silvia Muñoz-Price; Jesse T Jacob; Loreen A Herwaldt; Carol A Sulis; Deborah S Yokoe; Lisa Maragakis; Matthew E Lissauer; Marcus J Zervos; David K Warren; Robin L Carver; Deverick J Anderson; David P Calfee; Jason E Bowling; Nasia Safdar
Journal:  JAMA       Date:  2013-10-16       Impact factor: 56.272

10.  Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination.

Authors:  F Ruza; F Alvarado; R Herruzo; M A Delgado; S García; P Dorao; F Goded
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.